Cargando…

Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer

PURPOSE: As the number of elderly patients diagnosed with non-small cell lung carcinoma (NSCLC) increases, the number of these patients receiving chemotherapy also increases. However, limited data exists regarding the use of chemotherapy in advanced NSCLC patients who are 75 years of age or older. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seung Tae, Park, Kyong Hwa, Oh, Sang Cheul, Seo, Jae Hong, Kim, Jun Suk, Kim, Yeul Hong, Shin, Sang Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322199/ https://www.ncbi.nlm.nih.gov/pubmed/22500159 http://dx.doi.org/10.4143/crt.2012.44.1.37

Ejemplares similares

Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy
por: Kim, Seung Tae, et al.
Publicado: (2013)

Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
por: Kim, Seung Tae, et al.
Publicado: (2014)

The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer
por: Choi, Yoon Ji, et al.
Publicado: (2016)

Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
por: Lee, Jung Hyun, et al.
Publicado: (2014)

Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
por: Kim, Hong Jun, et al.
Publicado: (2020)

An Association Study of Polymorphisms in JAK3 Gene with Lung Cancer in the Korean Population
por: Yoo, Wonbeak, et al.
Publicado: (2011)

Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung Cancer
por: Sung, Jae Sook, et al.
Publicado: (2012)

The use of everolimus to target carcinogenic pathways in a patient with renal cell carcinoma and tuberous sclerosis complex: a case report
por: Kim, Hye Sook, et al.
Publicado: (2014)

Clinical Results of Cardiovascular Surgery in the Patients Older than 75 Years
por: Kim, Dong Jin, et al.
Publicado: (2014)

Case Report of Pulmonary Sarcoidosis Suspected to be Pulmonary Metastasis in a Patient with Breast Cancer
por: Kim, Hye Sook, et al.
Publicado: (2014)

A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
por: Choi, Jong Gwon, et al.
Publicado: (2012)

ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002)

Incidence and Risk Factors of Infectious Complications Related to Implantable Venous-Access Ports
por: Shim, Jisue, et al.
Publicado: (2014)

Incidence of and Risk Factors for Bundle Branch Block in Adults older than 40 years
por: Jeong, Joon Hoon, et al.
Publicado: (2004)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
por: Kim, Gun Min, et al.
Publicado: (2010)

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First‐line Therapy (KCSG ST10‐01)
por: Lee, Keun‐Wook, et al.
Publicado: (2018)

The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer
por: Kim, Hong Jun, et al.
Publicado: (2016)

Update of Adjuvant Chemotherapy for Resected Gastric Cancer
por: Oh, Sang Cheul
Publicado: (2012)

Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea
por: Lee, Soohyeon, et al.
Publicado: (2020)

Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and older
por: Kim, Jong Man, et al.
Publicado: (2021)

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis
por: Jeon, Ye Won, et al.
Publicado: (2019)

Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study
por: Kim, Ju Won, et al.
Publicado: (2019)

Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
por: Lee, Kyoungmin, et al.
Publicado: (2022)

Novel Systemic Therapies for Advanced Gastric Cancer
por: Kim, Hong Jun, et al.
Publicado: (2018)

Inhibition of Sphingolipid Metabolism Enhances Resveratrol Chemotherapy in Human Gastric Cancer Cells
por: Shin, Kyong-Oh, et al.
Publicado: (2012)

Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer
por: Hyun, Myung Han, et al.
Publicado: (2017)

Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors
por: Min, Byung-Joo, et al.
Publicado: (2021)

Novel Germline Mutation of BRCA1 Gene in a 56-Year-Old Woman with Breast Cancer, Ovarian Cancer, and Diffuse Large B-Cell Lymphoma
por: Kim, Hye Sook, et al.
Publicado: (2015)

Hematopoietic Differentiation of Embryoid Bodies Derived from the Human Embryonic Stem Cell Line SNUhES3 in Co-culture with Human Bone Marrow Stromal Cells
por: Kim, Seok Jin, et al.
Publicado: (2005)

Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma
por: Kim, Hye Sook, et al.
Publicado: (2013)

Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study
por: Park, Dong Jin, et al.
Publicado: (2023)

Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
por: Seol, Aeran, et al.
Publicado: (2022)

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population
por: Jo, Uk Hyun, et al.
Publicado: (2008)

Radical Prostatectomy in Korean Men Aged 75-Years or Older: Safety and Efficacy in Comparison with Patients Aged 65–69 Years
por: Ryu, Jae Hyun, et al.
Publicado: (2016)

"ALL ANTIDEPRESSANTS ARE CREATED EQUAL" (SOME ARE MORE EQUAL THAN OTHERS)
por: Doongaji, Dinshaw R
Publicado: (2000)

All insects are equal, but some insects are more equal than others
por: Fischer, Arnout R.H., et al.
Publicado: (2018)

Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study
por: Kim, Jin Won, et al.
Publicado: (2018)

The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA
por: Chang, Won Jin, et al.
Publicado: (2020)

The Usefulness of FEF(25–75) in Predicting Airway Hyperresponsiveness to Mannitol
por: Kim, Youlim, et al.
Publicado: (2021)

Outcomes of patients older than 75 years with non-metastatic prostate cancer
por: Amiya, Yoshiyasu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m7jigmg6ol2s3jh5sa0qoblksl